Clinical Trial Update: Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy [Phase 3]

View source ↗

Summary

Open-label safety and efficacy study of pregabalin for nerve pain in HIV-related peripheral neuropathy completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Peripheral Neuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Peripheral Neuropathy, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2009-03-23